Most Favored Nation pricing policies are evolving and complex. For manufacturers, the implications can be significant, particularly across Medicare Part B, Part D, and Medicaid programs.
This brief assessment is designed to help you quickly determine whether your product may be exposed to MFN-related pricing pressure or enforcement mechanisms. By answering a few structured questions, you will receive a strategic exposure assessment based on your product profile, including:
After completing the assessment, you will be able to review and discuss the results with our experts to explore implications, validate assumptions, and identify potential strategic next steps.
The output is not a legal determination. It is a strategic screening tool intended to surface risk early and guide informed discussion.